James Huang, Director at CASI Pharmaceuticals, Inc. (CASI), bought 428,442 shares at $3.50 ($1.4M) on 2022-08-23, disclosed to the SEC on 2022-08-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.27 | 171,116 | $560K | 39.4% |
| 2 | $3.27 | 171,116 | $560K | 39.4% |
| 3 | $3.46 | 23,105 | $80K | 5.6% |
| 4 | $3.46 | 23,105 | $80K | 5.6% |
| 5 | $3.50 | 40,000 | $140K | 9.9% |
| Total | $3.31 avg | 428,442 |
| $1.4M |
| 100% |
| Filing → |
| ATRA | SELL | 2026-01-14 | $489K | — | Filing → |
| ATRA | BUY | 2025-07-21 | $373K | — | Filing → |
| CASI | BUY | 2022-09-08 | $304K | — | Filing → |